2026
Ebert MP, et al.; Klinische Leitlinie: Kolorektales Karzinom Diagnostik, Therapie, Vor- und Nachsorge. Dtsch Arztebl Int 2025; 122: 729-34
Gobits R, et al.; Functional Precision Medicine Using MicroOrganoSpheres for Treatment Response Prediction in Advanced Colorectal Cancer. JCO Precis Oncol. 2026 Jan 15. doi:10.1200/PO-25-00501
Balzasch BM, et al.; Monocytes acquire a tumor-associated IL1B program upon encountering patient-derived colon cancer organoids. Oncoimmunology. 2026 Dec 31. doi:org/10.1080/2162402X.2026.2633012
Wiest IC, et al.; Differential effects of prior versus concomitant Steroid and Antibiotic Treatment on Immunotherapy Efficacy – A Pooled Analysis of the RAMONA, INTEGA, OPTIM, ELDORANDO, FORCE, TITAN-RCC and TITAN-TCC Trials of the German AIO Study Group. Br J Cancer 2026 March 24. doi:org/10.1038/s41416-026-03428-8
Venkatachalam N, et al.; Ras-MAPK inhibition induces AXIN1 loss in colorectal cancer by mTOR associated suppression of protein synthesis. Cell Commun Signal. 2026 May 27. doi: 10.1186/s12964-026-02963-4
Vaquero-Siguero N, et al.; TROP2 targeting reveals therapy-driven cell state dynamics in colorectal cancer. Nature 2026 May 26. doi:org/10.1038/s41586-026-10705-2
Feng X, et al.; The role of pharmacomicrobiomics in colorectal cancer therapy. Trends in Molecular Medicine 2026 August 12. DOI: 10.1016/j.molmed.2026.07.006
Mastel M, et al.; WNT-driven immune evasion promotes malignant transformation of BRAF-mutant colorectal cancer. Gastroenterology 2026 July 28. doi: 10.1053/j.gastro.2026.07.035